Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Serum neurofilament light… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Serum neurofilament light protein predicts clinical outcome in traumatic brain injury

Artikel i vetenskaplig tidskrift
Författare Pashtun Shahim
Magnus Gren
Victor Liman
Ulf Andreasson
N. Norgren
Y. Tegner
N. Mattsson
N. Andreasen
Martin Öst
Henrik Zetterberg
Bengt Nellgård
Kaj Blennow
Publicerad i Scientific Reports
Volym 6
ISSN 2045-2322
Publiceringsår 2016
Publicerad vid Institutionen för neurovetenskap och fysiologi
Institutionen för kliniska vetenskaper, Avdelningen för anestesiologi och intensivvård
Språk en
Länkar dx.doi.org/10.1038/srep36791
Ämnesord cerebrospinal-fluid, multiple-sclerosis, s-100b protein, s100b, biomarkers, disease, damage, severity, players, blood, Science & Technology - Other Topics
Ämneskategorier Neurovetenskap

Sammanfattning

Axonal white matter injury is believed to be a major determinant of adverse outcomes following traumatic brain injury (TBI). We hypothesized that measurement of neurofilament light protein (NF-L), a protein found in long white-matter axons, in blood samples, may serve as a suitable biomarker for neuronal damage in TBI patients. To test our hypotheses, we designed a study in two parts: i) we developed an immunoassay based on Single molecule array technology for quantification of NF-L in blood, and ii) in a proof-of-concept study, we tested our newly developed method on serial serum samples from severe TBI (sTBI) patients (n = 72) and controls (n = 35). We also compared the diagnostic and prognostic utility of NF-L with the established blood biomarker S100B. NF-L levels were markedly increased in sTBI patients compared with controls. NF-L at admission yielded an AUC of 0.99 to detect TBI versus controls (AUC 0.96 for S100B), and increased to 1.00 at day 12 (0.65 for S100B). Importantly, initial NF-L levels predicted poor 12-month clinical outcome. In contrast, S100B was not related to outcome. Taken together, our data suggests that measurement of serum NF-L may be useful to assess the severity of neuronal injury following sTBI.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?